Skip to main content

Functional Phosphoproteomics of Oncogenic KRAS Signaling

  • Protocol
  • First Online:
Ras Signaling

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1120))

  • 3633 Accesses

Abstract

Identification of oncogene-mediated phosphorylation events is essential to understanding the molecular determinants responsible for cancer development and progression. Here, we identify KRAS-regulated phosphorylation events using label-free quantitation-based comparative phosphoproteomics analyses of immortalized human bronchial epithelial cells that express oncogenic KRAS as well as cells that do not. Further, we demonstrate integration of the identified phosphorylation events with the Pathway Interaction Database to infer KRAS-regulated pathways, which may have implications in KRAS-associated lung adenocarcinoma development. Taken together, our study provides an overview of the functional phosphoproteomics approach involving cell culture, preparation of whole cell lysates, trypsin digestion, phosphopeptide enrichment, mass spectrometry analyses, label-free quantitative analyses, and signaling pathway analyses to study KRAS-targeted events.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30 years. Nat Rev Cancer 3:459–465

    Article  PubMed  CAS  Google Scholar 

  2. Riely GJ, Marks J, Pao W (2009) KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc 6:201–205

    Article  PubMed  CAS  Google Scholar 

  3. Qian J, Niu J, Li M et al (2005) In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res 65:5045–5053

    Article  PubMed  CAS  Google Scholar 

  4. Tchernitsa OI, Sers C, Zuber J et al (2004) Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 23:4536–4555

    Article  PubMed  CAS  Google Scholar 

  5. Sudhir PR, Chen CH, Pavana Kumari M et al (2012) Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells. Mol Cell Proteomics 11:901–915

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Guha U, Chaerkady R, Marimuthu A et al (2008) Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc Natl Acad Sci U S A 105:14112–14117

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Sudhir P-R, Hsu C-L, Wang M-J et al (2011) Phosphoproteomics identifies oncogenic ras signaling targets and their involvement in lung adenocarcinomas. PLoS One 6:e20199

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Beltran L, Cutillas PR (2012) Advances in phosphopeptide enrichment techniques for phosphoproteomics. Amino Acids 43:1009–1024

    Article  PubMed  CAS  Google Scholar 

  9. Ramirez RD, Sheridan S, Girard L et al (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64:9027–9034

    Article  PubMed  CAS  Google Scholar 

  10. Sato M, Vaughan MB, Girard L et al (2006) Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 66:2116–2128

    Article  PubMed  CAS  Google Scholar 

  11. Tsai CF, Wang YT, Chen YR et al (2008) Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics. J Proteome Res 7:4058–4069

    Article  PubMed  CAS  Google Scholar 

  12. Tsou CC, Tsai CF, Tsui YH et al (2010) IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol Cell Proteomics 9:131–144

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgment

This work was supported by the grant to JYC from National Research Program on Genomic Medicine, Taiwan and the postdoctoral fellowship to PRS from the Academia Sinica, Taiwan.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Sudhir, PR., Chen, JY. (2014). Functional Phosphoproteomics of Oncogenic KRAS Signaling. In: Trabalzini, L., Retta, S. (eds) Ras Signaling. Methods in Molecular Biology, vol 1120. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-791-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-791-4_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-790-7

  • Online ISBN: 978-1-62703-791-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics